Pablo Hernandez Romero, an associate in Goodwin’s Business Law department, advises private and public companies in startup and formation matters, venture capital financings, mergers and acquisitions, initial public offerings, capital market transactions, ongoing SEC compliance, and corporate governance matters. He joined Goodwin in 2020.
Representative Matters
- Zip in connection with its $190 million Series D preferred stock financing
- Aliro Technologies, Inc. in its Series A preferred stock financing
- Hon Hai Technology Group (FoxConn) in its investment of Indigo Technologies, Inc.
- Stuf in connection with its $11 million Series A preferred stock financing
- BitSight Technologies in connection with its $250 million Series E preferred stock financing
- Nimbus Therapeutics in connection with its $105 million and $210 million private stock financings
- Has represented numerous venture capital firms in early and stage seed financings through late-stage growth equity financings. Such firms include 8VC, a16z, Acrew Capital, Data Collective, Friends and Family Capital, Lux Capital, and Ribbit Capital.
Buy-Side Representation:
- Illumina, Inc. (NASDAQ: ILMN) in its acquisition of Partek Incorporated
- BitSight Technologies, Inc. in its acquisition of Northern Lights Group, Inc. (d/b/a Third Party Trust)
- Intellia Therapeutics, Inc. (NASDAQ: NTLA) in its acquisition of Rewrite Therapeutics, Inc.
- RBC Bearings Incorporated (NASDAQ: ROLL) in its acquisition of ABB’s Dodge Mechanical Power Transmission division
- Synaptics Incorporated (NASDAQ: SYNA) in its acquisition of DSP Group, Inc. (NASDAQ: DSPG)
- BitSight Technologies, Inc. in its acquisition of VisibleRisk, Inc.
- Cenexel Clinical Research, Inc. in connection with its acquisition of Clinical Innovations, Inc.
Sell-Side Representation:
- Parsable Inc. in its sale to CAI Software, LLC
- Thrive Earlier Detection Corp. in its sale to Exact Sciences Corp. (NASDAQ: EXAS)
- Minim Inc. in its sale to Zoom Telephonics, Inc. (NASDAQ: MINM)
- Great Hill Partners in connection with its sale of Quantum Health to Warburg Pincus
- Akero Therapeutics, Inc. in connection with its:
- $366.9 million follow-on offering
- Centessa Pharmaceuticals plc in connection with day-to-day governance and reporting matters and its:
- $100 million follow on offering
- upsized $379.5 million initial public offering
- $125 million “at the market” offering
- Cabaletta Bio, Inc. in connection with its:
- $100 million follow-on offering
- Intellia Therapeutics, Inc. in connection with day-to-day governance and reporting matters and its:
- $201 million follow-on offering
- $690 million follow-on offering
- $300 million bought deal
- $400 million “at the market” offering
Professional Activities
Pablo is a member of the Hispanic National Bar Association and the Boston Bar Association.
Professional Experience
Pablo was a summer associate at Goodwin in 2019 and a law clerk in the Private Equity and FinTech groups during the winter of 2019–2020. While attending law school, Pablo interned with the Civil Rights Unit of the U.S. Attorney’s Office for the District of Massachusetts and for the Honorable Norman H. Stahl of the United States Court of Appeals for the First Circuit.
During law school, Pablo served as a Senior Note Editor for the Northeastern University Law Review, as Co-chair of the Student Bar Association, and as Co-Chair of the Latin American Law Students Association.
Credentials
Education
JD2020
Northeastern University School of Law
MSc2013
The University of Edinburgh
BA2012
Earlham College
Admissions
Bars
- California
- Massachusetts